1. Article › Research › Peer-reviewed
  2. A novel class of tyrosyl-DNA phosphodiesterase 1 inhibitors that contains the octahydro-2H-chromen-4-ol scaffold

    Li-Zhulanov, N. S., Zakharenko, A. L., Chepanova, A. A., Patel, J., Zafar, A., Volcho, K. P., Salakhutdinov, N. F., Reynisson, J., Leung, I. K. H. & Lavrik, O. I., 26 Sept 2018, In: Molecules. 23, 10, 14 p., 2468.

    Research output: Contribution to journalArticlepeer-review

  3. Antimetastatic Activity of Combined Topotecan and Tyrosyl-DNA Phosphodiesterase-1 Inhibitor on Modeled Lewis Lung Carcinoma

    Koldysheva, E. V., Men’shchikova, A. P., Lushnikova, E. L., Popova, N. A., Kaledin, V. I., Nikolin, V. P., Zakharenko, A. L., Luzina, O. A., Salakhutdinov, N. F. & Lavrik, O. I., 15 Mar 2019, In: Bulletin of Experimental Biology and Medicine. 166, 5, p. 661-666 6 p.

    Research output: Contribution to journalArticlepeer-review

  4. Antitumor Activity of the Combination of Topotecan and Tyrosyl-DNA-Phosphodiesterase 1 Inhibitor on Model Krebs-2 Mouse Ascite Carcinoma

    Dyrkheeva, N. S., Zakharenko, A. L., Novoselova, E. S., Chepanova, A. A., Popova, N. A., Nikolin, V. P., Luzina, O. A., Salakhutdinov, N. F., Ryabchikova, E. I. & Lavrik, O. I., Mar 2021, In: Molecular Biology. 55, 2, p. 273-277 5 p.

    Research output: Contribution to journalArticlepeer-review

  5. Apurinic/Apyrimidinic Endonuclease 1 and Tyrosyl-DNA Phosphodiesterase 1 Prevent Suicidal Covalent DNA-Protein Crosslink at Apurinic/Apyrimidinic Site

    Lebedeva, N. A., Rechkunova, N. I., Endutkin, A. V. & Lavrik, O. I., 11 Jan 2021, In: Frontiers in Cell and Developmental Biology. 8, 8 p., 617301.

    Research output: Contribution to journalArticlepeer-review

  6. A rapid fluorescent method for the real-time measurement of poly(ADP-ribose) polymerase 1 activity

    Kurgina, T. A., Anarbaev, R. O., Sukhanova, M. V. & Lavrik, O. I., 15 Mar 2018, In: Analytical Biochemistry. 545, p. 91-97 7 p.

    Research output: Contribution to journalArticlepeer-review

  7. Autoimmunity and immune system dysregulation in schizophrenia: IgGs from sera of patients hydrolyze myelin basic protein

    Parshukova, D., Smirnova, L. P., Ermakov, E. A., Bokhan, N. A., Semke, A. V., Ivanova, S. A., Buneva, V. N. & Nevinsky, G. A., 1 Feb 2019, In: Journal of Molecular Recognition. 32, 2, 13 p., e2759.

    Research output: Contribution to journalArticlepeer-review

  8. A versatile strategy for the design and synthesis of novel ADP conjugates and their evaluation as potential poly(ADP-ribose) polymerase 1 inhibitors

    Sherstyuk, Y. V., Zakharenko, A. L., Kutuzov, M. M., Chalova, P. V., Sukhanova, M. V., Lavrik, O. I., Silnikov, V. N. & Abramova, T. V., 1 Feb 2017, In: Molecular Diversity. 21, 1, p. 101-113 13 p.

    Research output: Contribution to journalArticlepeer-review

  9. Biotin-decorated anti-cancer nucleotide theranostic conjugate of human serum albumin: Where the seed meets the soil?

    Popova, T. V., Khan, H., Chubarov, A. S., Lisitskiy, V. A., Antonova, N. M., Akulov, A. E., Shevelev, O. B., Zavjalov, E. L., Silnikov, V. N., Ahmad, S. & Godovikova, T. S., 1 Feb 2018, In: Bioorganic and Medicinal Chemistry Letters. 28, 3, p. 260-264 5 p.

    Research output: Contribution to journalArticlepeer-review

  10. Blood-Derived RNA- and microRNA-Hydrolyzing IgG Antibodies in Schizophrenia Patients

    Ermakov, E. A., Ivanova, S. A., Buneva, V. N. & Nevinsky, G. A., 1 May 2018, In: Biochemistry (Moscow). 83, 5, p. 507-526 20 p.

    Research output: Contribution to journalArticlepeer-review

  11. Catalase activity of IgG antibodies from the sera of healthy donors and patients with schizophrenia

    Ermakov, E. A., Smirnova, L. P., Bokhan, N. A., Semke, A. V., Ivanova, S. A., Buneva, V. N. & Nevinsky, G. A., 1 Sept 2017, In: PLoS ONE. 12, 9, p. e0183867 25 p., e0183867.

    Research output: Contribution to journalArticlepeer-review

Previous 1 2 3 4 5 6 7 8 ...18 Next

ID: 3082212